OMB APPROVAL
OMB Number:   3235-0145 
Expires:   February 28, 2010 
Estimated average burden
hours per response   10.4 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(AMENDMENT NO 5)*

 

 

Obalon Therapeutics, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

67424L209

(CUSIP Number)

December 31, 2019

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

Page 1 of 10 Pages


Cusip No. 67424L209    13G    Page 2 of 10 Pages

 

  1    

  NAME OF REPORTING PERSONS

 

  InterWest Partners X, LP (“IWP X”)

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  California

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  398,974

   6   

  SHARED VOTING POWER

 

  0

   7   

  SOLE DISPOSITIVE POWER

 

  398,974

   8   

  SHARED DISPOSITIVE POWER

 

  0

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  398,974 (1)

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES:

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.2% (2)

12  

  TYPE OF REPORTING PERSON

 

  PN

 

(1)

The shares are owned by IWP X and include (i) 380,224 shares of Common Stock and (ii) 18,750 shares of Common Stock issuable pursuant to common stock purchase warrants.

(2)

Based upon 7,694,576 shares of the Issuer’s Common Stock outstanding as of November 6, 2019, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 8, 2019.

 

Page 2 of 10 Pages


Cusip No. 67424L209    13G    Page 3 of 10 Pages

 

  1    

  NAME OF REPORTING PERSONS

 

  InterWest Management Partners X, LLC (the General Partner of InterWest Partners X, LP)

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  California

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  398,974

    6   

  SHARED VOTING POWER

 

  0

    7   

  SOLE DISPOSITIVE POWER

 

  398,974

    8   

  SHARED DISPOSITIVE POWER

 

  0

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  398,974 (1)

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES:

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.2% (2)

12  

  TYPE OF REPORTING PERSON

 

  OO

 

(1)

The shares are owned by IWP X and include (i) 380,224 shares of Common Stock and (ii) 18,750 shares of Common Stock issuable pursuant to common stock purchase warrants.

(2)

Based upon 7,694,576 shares of the Issuer’s Common Stock outstanding as of November 6, 2019, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 8, 2019.

 

Page 3 of 10 Pages


Cusip No. 67424L209    13G    Page 4 of 10 Pages

 

  1    

  NAME OF REPORTING PERSONS

 

  Keval Desai (a Venture Member of InterWest Management Partners X, LLC)

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  0

   6   

  SHARED VOTING POWER

 

  398,974

   7   

  SOLE DISPOSITIVE POWER

 

  0

   8   

  SHARED DISPOSITIVE POWER

 

  398,974

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  398,974

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES:

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.2%

12  

  TYPE OF REPORTING PERSON

 

  IN

Neither the filing of this statement on Schedule 13G nor any of its contents shall be deemed to constitute an admission by Keval Desai that he is the beneficial owner of any of the Common Stock referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose.

 

Page 4 of 10 Pages


Cusip No. 67424L209    13G    Page 5 of 10 Pages

 

  1    

  NAME OF REPORTING PERSONS

 

  Gilbert H. Kliman (a Managing Director of InterWest Management Partners X, LLC)

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  0

    6   

  SHARED VOTING POWER

 

  398,974

    7   

  SOLE DISPOSITIVE POWER

 

  0

    8   

  SHARED DISPOSITIVE POWER

 

  398,974

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  398,974

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES:

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.2%

12  

  TYPE OF REPORTING PERSON

 

  IN

Neither the filing of this statement on Schedule 13G nor any of its contents shall be deemed to constitute an admission by Gilbert H. Kliman that he is the beneficial owner of any of the Common Stock referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose.

 

Page 5 of 10 Pages


Cusip No. 67424L209    13G    Page 6 of 10 Pages

 

  1    

  NAME OF REPORTING PERSONS

 

  Khaled A. Nasr (a Venture Member of InterWest Management Partners X, LLC)

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  0

    6   

  SHARED VOTING POWER

 

  398,974

    7   

  SOLE DISPOSITIVE POWER

 

  0

    8   

  SHARED DISPOSITIVE POWER

 

  398,974

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  398,974

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES:

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.2%

12  

  TYPE OF REPORTING PERSON

 

  IN

Neither the filing of this statement on Schedule 13G nor any of its contents shall be deemed to constitute an admission by Khaled A. Nasr that he is the beneficial owner of any of the Common Stock referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose.

 

Page 6 of 10 Pages


Cusip No. 67424L209    13G    Page 7 of 10 Pages

 

  1    

  NAME OF REPORTING PERSONS

 

  Arnold L. Oronsky (a Managing Director of InterWest Management Partners X, LLC)

  2  

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

  (a)  ☐        (b)  ☐

 

  3  

  SEC USE ONLY

 

  4  

  CITIZENSHIP OR PLACE OF ORGANIZATION

 

  United States

NUMBER OF

SHARES

 BENEFICIALLY 

OWNED BY

REPORTING

PERSON

WITH

    5     

  SOLE VOTING POWER

 

  0

   6   

  SHARED VOTING POWER

 

  398,974

   7   

  SOLE DISPOSITIVE POWER

 

  0

   8   

  SHARED DISPOSITIVE POWER

 

  398,974

  9    

  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

  398,974

10  

  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES:

 

  ☐

11  

  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

  5.2%

12  

  TYPE OF REPORTING PERSON

 

  IN

Neither the filing of this statement on Schedule 13G nor any of its contents shall be deemed to constitute an admission by Arnold L. Oronsky that he is the beneficial owner of any of the Common Stock referred to herein for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, or for any other purpose.

 

Page 7 of 10 Pages


Cusip No. 67424L209    13G    Page 8 of 10 Pages

 

ITEM 1.

 

(a)

NAME OF ISSUER: Obalon Therapeutics, Inc.

 

(b)

ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICE:

5421 Avenida Encinas, Suite F, Carlsbad, CA 92008

 

ITEM 2.

 

(a)

NAME OF PERSON(S) FILING:

InterWest Partners X, LP (“IWP X”)

InterWest Management Partners X, LLC (“IMP X”)

Keval Desai (“Desai”)

Gilbert H. Kliman (“Kliman”)

Khaled A. Nasr (“Nasr”)

Arnold L. Oronsky (“Oronsky”)

 

(b)

ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

2710 Sand Hill Road, Suite 200, Menlo Park, CA 94025

 

(c)

CITIZENSHIP/PLACE OF ORGANIZATION:

 

IWP X:    California
IMP X:    California
Desai:    United States
Kliman:    United States
Nasr:    United States
Oronsky:    United States

 

(d)

TITLE OF CLASS OF SECURITIES: Common Stock

 

(e)

CUSIP NUMBER: 67424L209

ITEM 3. NOT APPLICABLE.

 

Page 8 of 10 Pages


Cusip No. 67424L209    13G    Page 9 of 10 Pages

 

ITEM 4. OWNERSHIP.

 

     IWP X     IMP X (1)     Desai (2)  

Beneficial Ownership

     398,974  (3)      398,974  (3)      398,974  (3) 

Percentage of Class

     5.2 % (4)      5.2 % (4)      5.2 % (4) 

Sole Voting Power

     398,974       398,974       0  

Shared Voting Power

     0       0       398,974  

Sole Dispositive Power

     398,974       398,974       0  

Shared Dispositive Power

     0       0       398,974  

 

     Kliman (2)     Nasr (2)     Oronsky (2)  
Beneficial Ownership      398,974  (3)      398,974  (3)      398,974  (3) 
Percentage of Class      5.2 % (4)      5.2 % (4)      5.2 % (4) 
Sole Voting Power      0       0       0  
Shared Voting Power      398,974       398,974       398,974  
Sole Dispositive Power      0       0       0  

Shared Dispositive Power

     398,974       398,974       398,974  

 

(1)

IMP X is the general partner of IWP X.

(2)

Kliman and Oronsky are Managing Directors of IMP X. Desai and Nasr are Venture Members of IMP X. The Managing Directors and Venture Members of IMP X share voting and investment control over shares held by IWP X.

(3)

The shares are owned by IWP X and include (i) 380,224 shares of Common Stock and (ii) 18,750 shares of Common Stock issuable pursuant to common stock purchase warrants.

(4)

Based upon 7,694,576 shares of the Issuer’s Common Stock outstanding as of November 6, 2019, as reported in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 8, 2019.

ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

Not applicable.

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.

Under certain circumstances set forth in the limited liability company operating agreement of IMP X, the members of such limited liability company have the right to receive dividends from, or the proceeds from the sale of, the common stock of Issuer beneficially owned by such limited liability company.

ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.

Not applicable.

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.

No reporting person is a member of a group as defined in section 240.13d-1(b)(1)(iii)(H) of the Act.

ITEM 9. NOTICE OF DISSOLUTION OF THE GROUP.

Not applicable.

 

Page 9 of 10 Pages


Cusip No. 67424L209    13G    Page 10 of 10 Pages

 

ITEM 10. CERTIFICATION.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

EXHIBITS

Joint Filing Statement attached as Exhibit A.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2020

 

INTERWEST PARTNERS X, LP
By:   InterWest Management Partners X, LLC, its General Partner
By:   /s/ Gilbert H. Kliman by Karen A. Wilson, Power of Attorney
  Managing Director
INTERWEST MANAGEMENT PARTNERS X, LLC
By:   /s/ Gilbert H. Kliman by Karen A. Wilson, Power of Attorney
  Managing Director
By:   /s/ Keval Desai by Karen A. Wilson, Power of Attorney
Name:   Keval Desai
By:   /s/ Gilbert H. Kliman by Karen A. Wilson, Power of Attorney
Name:    Gilbert H. Kliman
By:   /s/ Khaled A. Nasr
Name:   Khaled A. Nasr
By:   /s/ Arnold L. Oronsky
Name:   Arnold L. Oronsky

 

Page 10 of 10 Pages

Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more Obalon Therapeutics Charts.
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more Obalon Therapeutics Charts.